EXTON, Pa.--(BUSINESS WIRE)--March 6, 2006--Antares Pharma, Inc. (Amex:AIS) announced today that it has completed its previously announced financing of $10,962,500 through a private placement of units consisting of 8,770,000 shares of common stock at $1.25 per share and warrants to purchase 6,577,500 shares of common stock at an exercise price of $1.50 per share. The accredited investors include SDS Capital Partners, LLC, and Perceptive Advisors, LLC. SCO Securities, LLC and Dawson James Securities, Inc. acted as placement agents for the financing.
